However, anti-PD-L1 antibodies, which comprise a functional IgG1-Fc, demonstrate improved efficacy in vivo (43), which was linked to antibody-mediated effector functions against PD-L1 positive tumor cells (44). Here, CD274 is linked to neoplasm.